What Is the Secretome?
The secretome refers to the full collection of molecules that cells secrete into their surrounding environment — not the cells themselves. These secreted molecules include proteins, signaling peptides, and extracellular vesicles that influence the behavior of nearby and distant cells.
Understanding the secretome begins with recognizing that cells don’t work in isolation. They continuously broadcast signals to one another through a rich mixture of chemical messengers.
- Growth factors — proteins that stimulate cellular growth, proliferation, and differentiation
- Cytokines — small signaling proteins that modulate immune responses and inflammation
- Chemokines — a cytokine subset that directs cell migration
- Extracellular vesicles — membrane-bound particles carrying proteins and nucleic acids between cells
- Regulatory RNAs — including microRNAs, which influence gene expression post-transcriptionally
- Matrix components — proteins that form the structural scaffolding of tissue environments
The Future of Secretome Science
For decades, regenerative research focused heavily on the cells themselves — transplanting them into damaged tissue with the expectation that they would engraft and rebuild. Increasingly, researchers are finding that many effects appear to be mediated not by transplanted cells surviving long-term, but by the signals those cells emit shortly after introduction.
- Acellular biologics — secretome preparations that retain signaling molecules without live cells
- Extracellular vesicle characterization — understanding what EVs carry and how they interact with target cells
- miRNA signaling — how regulatory RNAs within vesicles may influence gene expression in recipient cells
- Transcriptomic characterization — identifying the full molecular profile of secretome preparations
- Product standardization — developing consistent quality and testing standards for secretome research material
- Clinician-governed use — frameworks for responsible professional engagement with secretome science
Signals, Not Cells — Secretome vs. Exosomes vs. Cell Factors
When stem cells are introduced into a tissue environment, evidence suggests that a significant portion of their observed effects occurs through paracrine signaling — the release of molecules that influence nearby cells — rather than through engraftment or direct replacement of tissue.
| Category | What it involves | Key distinction |
|---|---|---|
| Live-cell therapy | Administration of living cells | Relies on cell survival and engraftment |
| Exosome products | Isolated vesicular component of the secretome | One category within the broader secretome |
| Acellular secretome preparations | Conditioned media or processed secretome fractions | No live cells; signaling molecules remain |
| Cell factors | Broader signaling preparations from defined cell sources | May include multiple vesicular and soluble components |
Acellular Biology & Six-Compartment Placental Sourcing
Acellular secretome preparations contain no live cells. They are not stem cell transplants, do not rely on engraftment, and do not introduce living biological material that could persist, divide, or differentiate. What remains is the signaling environment the cells created.
Secretome research materials derived from placental and perinatal tissues may draw from multiple anatomical compartments, each with distinct cell populations and secretome profiles:
- Wharton’s Jelly — the gelatinous connective tissue of the umbilical cord
- Umbilical Cord Blood — rich in hematopoietic and mesenchymal progenitor cells
- Amniotic Fluid — contains growth factors and cells shed from the developing fetus
- Amnion — the inner membrane of the amniotic sac
- Chorion — the outer placental membrane
- Placental Body — the primary organ of nutrient and gas exchange during gestation
Evidence Status
Honest science communication requires separating what is known from what remains investigational. Secretome research is active and rapidly evolving. The evidence base is real — and it is incomplete.
| Evidence domain | What we know | What remains open |
|---|---|---|
| Cell biology | Cells secrete complex mixtures of signaling molecules that influence neighboring cell behavior | Precise mechanisms of action for most secretome preparations in human biology |
| Preclinical research | Animal and in vitro studies show meaningful biological activity for many secretome components | Whether preclinical effects translate reliably to human outcomes |
| Human data | Early human studies exist for some secretome-adjacent interventions | Large-scale, controlled clinical trial data for most applications |
| Regulatory status | Regulatory agencies actively monitor and evaluate this category | Final regulatory frameworks for many secretome preparations |
miRNA & Epigenetic Signaling
Among the most studied cargo carried inside extracellular vesicles are microRNAs (miRNAs) — short, non-coding RNA sequences roughly 20–24 nucleotides long. Unlike messenger RNA, miRNAs do not code for proteins. Instead, they regulate gene expression after transcription, typically by binding to complementary messenger RNA and reducing how much of a given protein a cell produces.
The reason miRNAs matter to secretome science is that they can travel. Packaged inside vesicles, secreted miRNAs may reach neighboring or distant cells and influence which genes those recipient cells express — a proposed form of intercellular communication that operates above the level of the genome itself.
- Vesicular packaging — miRNAs are partially protected from degradation inside extracellular vesicles, allowing them to persist in circulation
- Post-transcriptional control — a single miRNA can influence many target transcripts, and many miRNAs can converge on one pathway
- Context dependence — the same miRNA may have different effects depending on the recipient cell type and its state
- Characterization challenge — defining which miRNAs are present, in what quantity, and whether they are functionally delivered remains an active research problem